Fewer than a dozen peptides developed outside Western regulatory systems have attracted as much sustained research attention as Semax — a synthetic heptapeptide that Russian scientists have studied for over three decade…
Intranasal administration of Semax achieves approximately 60-70% bioavailability to central compartments, compared to under 5% via oral routes. That single data point explains why researchers consistently choose the nas…
Only 0.093% of an administered dose reaches brain tissue per gram, yet that fraction is roughly nine times higher than what intravenous delivery achieves. That single data point sits at the center of every serious discu…